Dermabrasion in Mohs: Split-Scar Trial

NCT07213921 — Not applicable, Completed, 29 participants, University of Wisconsin, Madison

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Intraoperative Dermabrasion in Mohs Surgery: A Randomized Split-Scar Trial

RegistryNCT07213921
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: double, treatment
Enrollment29 (Actual)
SponsorUniversity of Wisconsin, Madison (Other)
ConditionsWound Heal
InterventionsDermabrasion (Procedure)
Datesstart 2025-10-23, primary completion 2026-07-30, completion 2026-07-30, first posted 2025-10-09, last updated 2026-09-04
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Wound Heal All trials of Dermabrasion

-Summary

The purpose of this study is to determine the potential influence of intraoperative dermabrasion on scars following Mohs Micrographic Surgery (MMS). Researchers are trying to determine if dermabrasion, a method to gently remove the top layer of your skin, is a good or bad tool to improve scar appearance after healing. The use of dermabrasion technique in this study is considered investigational. 50 participants will be enrolled and on study for up to 6 months.

Expand all sections  ·  Collapse all

+Detailed description

Primary Objective: Scar assessment at 3 months postoperatively by utilizing observer component of Patient and Observer Scar Assessment Scale (POSAS)

Secondary Objectives:

* Patient portion of POSAS
* Overall patient opinion of scar appearance
* Complication rate

+Arms and interventions

ArmTypeInterventionsDescription
A: Superior Side of the WoundExperimentalProcedure: DermabrasionThe participant's wound will be labeled A if it is on the left or superior side of the investigator
B: Inferior Side of the WoundExperimentalProcedure: DermabrasionThe participant's wound will be labeled B if it is on the right or inferior side of the investigator
  • Dermabrasion (Procedure), also known as electrocautery scratch pad: First, both sides of the wound will be sutured together with a subcutaneous (bottom) layer of stitches. Next, a predetermined, concealed randomization number will be obtained which will specify which side, A or B, will be treated with dermabrasion. An electrocautery scratch pad will be used along the wound edge of the intervention side until pin-point bleeding is achieved. This will add no additional time to the standard of care surgery time. The wound will then be closed with an epidermal (top) layer of stitches, as is the standard of care.

+Outcome measures

Primary outcomes

  • POSAS Observer Score at 3 months post-surgery [3 months post-surgery]: The investigators hypothesize that the side of the wound treated with intraoperative dermabrasion will have superior cosmesis as evaluated by the observer components of POSAS when evaluated at 3 months postoperatively. Two blinded reviewers will provide the POSAS Observer score which evaluates scar vascularity, pigmentation, thickness, relief, pliability, and surface area, each from 1 to 10 where higher scores indicate worse scars. Total scores are summed and range from 6-60.

Secondary outcomes

  • POSAS Patient Score at 3 months post-surgery [3 months post-surgery]: The investigators hypothesize that the side of the wound treated with intraoperative dermabrasion will have superior cosmesis as evaluated by the patient components of POSAS when evaluated at 3 months postoperatively. The POSAS Patient score evaluates scar pain, itching, color, stiffness, thickness, and irregularity, each from 1 to 10 where higher scores indicate worse symptoms or physical scar characteristics. Total scores are summed and range from 6-60.
  • POSAS Overall Patient Opinion Score at 3 months post-surgery [3 months post-surgery]: The investigators hypothesize that the side of the wound treated with intraoperative dermabrasion will have superior cosmesis as evaluated by the patient components of POSAS when evaluated at 3 months postoperatively. The POSAS overall patient opinion score ranges from 1 to 10 where higher scores indicate worse symptoms or physical scar characteristics.
  • Number of Complications [3 months post-surgery]

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Able to give informed consent themselves
* Scheduled for cutaneous surgical procedure on the face or neck with predicted linear closure greater than 4 centimeters.
* Willing to return for follow up visit within the evaluation period

Exclusion Criteria:

* Patients with impaired decision-making capacity
* Significant vision or hearing impairments
* Pregnant Individuals
* Incarceration
* Wounds with predicted closure length less than 4 cm

+Locations (1)

FacilityCityCountryStatus
UW Health Mohs Surgery ClinicMadison, WisconsinUnited States

+Investigators